info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Rasagiline (Azilect)
506
Article source: Seagull Pharmacy
Nov 13, 2025

Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor. Since its approval by the U.S. FDA in 2006, it has become an important treatment option for Parkinson's disease. Its precise indication positioning, standardized dosage form design, and standardized storage requirements constitute the core elements of clinical medication use.

Indications for Rasagiline (Azilect)

Core Therapeutic Area

Rasagiline is clearly indicated for the treatment of Parkinson's disease (PD), covering disease management across different stages from early to advanced.

The medication can be used as monotherapy or a key component of combination therapy regimens.

Clinical Application Scenarios

Monotherapy: For patients with early-stage Parkinson's disease who have not received levodopa treatment.

Combination therapy: Used as an adjunct to levodopa to improve motor fluctuation symptoms.

Special populations: Can be used in combination with other anti-Parkinsonian medications such as dopamine agonists.

Specifications and Properties of Rasagiline (Azilect)

0.5 mg Tablets

White to off-white, round, flat tablets with beveled edges. One side is imprinted with "GIL 0.5", and the other side is a smooth surface.

1 mg Tablets

White to off-white, round, flat tablets with beveled edges. One side is imprinted with "GIL 1", and the other side remains smooth.

Both dosage forms use the same excipient formula: mannitol, starch, pregelatinized starch, colloidal silicon dioxide, stearic acid, and talc, ensuring drug stability and bioavailability.

Storage Methods for Rasagiline (Azilect)

Temperature Control Standards

The medication should be stored at 25°C (77°F), with short-term fluctuations allowed within the range of 15°C to 30°C (59°F to 86°F).

Packaging and Environmental Requirements

Packaging specifications: Supplied in bottles containing 30 tablets.

Environmental protection: Avoid exposure to direct sunlight, humid environments, and contact with heat sources.

Safety Precautions

Immediately seal the bottle cap after each use.

Store in a safe location out of the reach of children.

Avoid storing together with strong oxidants, acids, or alkalis.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, and an important medication for the treatment of Parkinson's disease.How to Purchase Rasagiline (Az...
What Are the Side Effects of Resmetirom (Rezdiffra)?
Resmetirom (Rezdiffra) is the first thyroid hormone receptor-beta agonist approved by the U.S. FDA in 2024 through the accelerated approval pathway for the treatment of non-cirrhotic non-alcoholic ste...
Precautions for Using Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta (THR-β) agonist and the first targeted drug approved for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to ...
How to Use Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta agonist approved for marketing by the U.S. FDA in 2024. When used in combination with diet and exercise, this medication is indicated for the ...
How to Use Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, which was first approved for marketing in the United States in 2006. This medication is indicated for t...
Precautions for Using Rasagiline (Azilect)
Rasagiline (Azilect) is one of the important medications currently used for the treatment of Parkinson's disease. As a monoamine oxidase (MAO) inhibitor, this drug carries specific risks such as h...
What Are the Side Effects of Rasagiline (Azilect)?
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, approved for the treatment of Parkinson's disease. While this medication effectively improves motor...
How to Purchase Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is a next-generation kinase inhibitor and an important targeted medication for the treatment of ROS1-positive non-small cell lung cancer (NSCLC) and NTRK gene fusion-positive s...
Related Articles
Mercaptopurine Tablets: Side Effect Management and Storage Guidelines
Mercaptopurine is a chemotherapy drug used to treat acute lymphoblastic leukemia. Understanding its side effects, mastering relief methods, and proper storage are crucial for treatment safety.1. Commo...
Indications, contraindications, and use in special populations for Mercaptopurine Tablets
Mercaptopurine is a chemotherapy drug used to treat acute lymphoblastic leukemia. Clarifying its indications, contraindications, and key points for use in special populations is crucial for treatment ...
Major Side Effects of Cevimeline
Cevimeline is used to improve dry mouth caused by Sjögren's syndrome, but it may cause various side effects when used.I. Major Side Effects of Cevimeline1. Digestive System Side Effects(1) The mos...
Cevimeline: Indications, Contraindications, and Use in Special Populations
Cevimeline is a cholinergic agonist that primarily promotes salivation by stimulating M receptors in the salivary glands.I. Indications1. Core IndicationCevimeline is indicated only for the improvemen...
Indications of Infigratinib
Infigratinib is an oral kinase inhibitor targeting FGFR2, indicated for patients with specific gene mutations in cholangiocarcinoma.I. Indications1. Infigratinib is indicated for adult patients with p...
Common Side Effects of Infigratinib
Infigratinib has shown clear efficacy in the treatment of FGFR2-mutant cholangiocarcinoma, but may also cause various side effects.I. Common Side Effects1. Ocular Side Effects:(1) The most common ocul...
What is Momelotinib?
Momelotinib is an oral kinase inhibitor indicated for the treatment of adults with intermediate or high-risk myelofibrosis with anemia, including primary and secondary myelofibrosis.I. What is Momelot...
What are the common side effects of Momelotinib
Momelotinib is a targeted therapy used for the treatment of intermediate/high-risk myelofibrosis with anemia. Understanding its common side effects, mastering management strategies, and proper storage...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved